Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

165 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q1 2022.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92.6M shares of 316M outstanding shares and own 29.31% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), TPG GP A, LLC (16.2M shares), VANGUARD GROUP INC (12.8M shares), Eversept Partners, LP (5.49M shares), Neuberger Berman Group LLC (3.2M shares), Point72 Asset Management, L.P. (3M shares), STATE STREET CORP (2.45M shares), Nuveen Asset Management, LLC (2.08M shares), GEODE CAPITAL MANAGEMENT, LLC (1.71M shares), and DIMENSIONAL FUND ADVISORS LP (1.64M shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.